IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2016 Holdings

Filed 2016-05-16 | 16 holdings | $171.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc.(ABBV)COM00287Y109$90.2M1,580,00052.7%
Biogen Inc(BIIB)COM09062X103$80.7M310,00047.1%
Ariad Pharmaceuticals IncCOM04033A100$82.1K12,850,0000.0%
Medicines CoCOM584688105$55.7K1,752,0000.0%
Quest Diagnostics Inc(DGX)COM74834L100$41.1K575,0000.0%
Pacira Pharmaceuticals Inc(PCRX)COM695127100$28.2K532,2000.0%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$18.8K675,0000.0%
Raptor Pharmaceutical CorpCOM75382F106$12.5K2,725,0000.0%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$10.7K633,0000.0%
Aegerion Pharmaceuticals IncCOM00767E102$9.5K2,580,0000.0%
Array Biopharma Inc(ARRYEUR)COM04269X105$8.5K2,875,0000.0%
Apricus Biosciences IncCOM03832V109$8.4K14,479,0520.0%
Vivus IncCOM928551100$3.6K2,573,9430.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$2.1K2,313,7590.0%
Repros Therapeutics IncCOM NEW76028H209$9701,001,0000.0%
Targacept IncNOTE 2/187611RAA6$680$680,3990.0%